Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Appel LJ, Robinson KA, Guallar E. Utility of Blood Pressure Monitoring Outside of the Clinic Setting. Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Nov. (Evidence Reports/Technology Assessments, No. 63.)

This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Utility of Blood Pressure Monitoring Outside of the Clinic Setting

Utility of Blood Pressure Monitoring Outside of the Clinic Setting.

Contents

Evidence Tables

Evidence Tables Index

Evidence Table 1: Summary of quality characteristics for articles addressing question #1a-c

Evidence Table 2: Summary of population characteristics for articles addressing question #1a-c

Evidence Table 3: Summary of clinic measurement for articles addressing question #1a-c

Evidence Table 4: Summary of self measurement for articles addressing question #1a-c

Evidence Table 5: Summary of ambulatory measurement for articles addressing question #1a-c

Evidence Table 6: Distribution of readings between clinic and self-measured blood pressure (question #1a)

Evidence Table 7: Distribution of readings between clinic blood pressure and ambulatory blood pressure measurement, systolic (question #1a)

Evidence Table 8: Distribution of readings between clinic and ambulatory blood pressure, diastolic (question #1a)

Evidence Table 9: Distribution of readings between self-measured blood pressure and ambulatory blood pressure measurement, systolic (question #1a)

Evidence Table 10: Distribution between self-measured blood pressure and ambulatory blood pressure measurement, diastolic (question #1a)

Evidence Table 11: Prevalence of white coat hypertension by self-measured blood pressure (question #1b)

Evidence Table 12: Prevalence of white coat hypertension by ambulatory blood pressure (question #1c)

Evidence Table 13: Reproducibility of white coat hypertension (WCH) (question #1c)

Evidence Table 14: Summary of quality characteristics for articles addressing question #2

Evidence Table 15: Summary of population characteristics for articles addressing question #2

Evidence Table 16: Summary of clinic measurements for articles addressing question #2

Evidence Table 17: Summary of self measurement for articles addressing question #2

Evidence Table 18: Characteristics of measures of left ventricular mass (question #2)

Evidence Table 19: Correlation of clinic and self-measured blood pressure with left ventricular mass (question #2)

Evidence Table 20: Characteristics of albuminuria measurement (question #2)

Evidence Table 21: Correlation of clinic and self-measured blood pressure with albuminuria (question #2)

Evidence Table 22: Summary of quality characteristics for prospective studies addressing question #2 (question #2b)

Evidence Table 23: Summary of population characteristics for prospective studies addressing question #2 (question #2b)

Evidence Table 24: Summary of clinic measurement characteristics for prospective studies (question #2b)

Evidence Table 25: Summary of self measurement characteristics for prospective studies addressing question #2 (question #2b)

Evidence Table 26: Summary of methods in prospective studies (question #2b)

Evidence Table 27: Prediction of outcome by clinic blood pressure and self-measured blood pressure (question #2b)

Evidence Table 28: Summary of quality characteristics for self-measured blood pressure trials (question #2d)

Evidence Table 29: Summary of population characteristics for self-measured blood pressure trials (question #2d)

Evidence Table 30: Summary of methods for self-measured blood pressure trials (question #2d)

Evidence Table 31: Characteristics of outcome measurements in self-measured blood pressure trials (question #2d)

Evidence Table 32: Results of self-measured blood pressure trials (question #2d)

Evidence Table 33: Summary of quality characteristics for articles addressing question #3

Evidence Table 34: Summary of population characteristics for articles addressing question #3

Evidence Table 35: Summary of clinic measurement characteristics for articles addressing question #3

Evidence Table 36: Summary of ambulatory blood pressure measurement for articles addressing question #3

Evidence Table 37: Characteristics of measures of left ventricular mass (question #3)

Evidence Table 38: Correlation of clinic and ambulatory blood pressure with left ventricular mass (question #3)

Evidence Table 39: Correlation of left ventricular mass with ambulatory blood pressure defined white coat hypertension (question #3)

Evidence Table 40: Characteristics of albuminuria measurement (question #3)

Evidence Table 41: Correlations of clinic and ambulatory blood pressure with albuminuria (question #3)

Evidence Table 42: Correlation of ambulatory blood pressure defined white coat hypertension with albuminuria (question #3)

Evidence Table 43: Summary of quality characteristics for prospective studies addressing question #3 (question #3b)

Evidence Table 44: Summary of population characteristics for prospective studies of ambulatory blood pressure measurement (question #3b)

Evidence Table 45: Summary of methods for prospective studies of ambulatory blood pressure measurement (question #3b)

Evidence Table 46: Prediction of outcome by clinic blood pressure and systolic ambulatory blood pressure (question #3b)

Evidence Table 47: Prediction of outcome by clinic blood pressure and diastolic ambulatory blood pressure (question #3b)

Evidence Table 48: Prediction of Outcome by pattern of ambulatory blood pressure (white coat hypertension and dipping status) (question #3b)

Evidence Table 49: Summary of quality characteristics in ambulatory blood pressure measurement trials (question #3d)

Evidence Table 50: Summary of population characteristics for ambulatory blood pressure measurement trials (question #3d)

Evidence Table 51: Summary of methods in ambulatory blood pressure measurement trials (question #3d)

Evidence Table 52: Characteristics of outcome measurements in ambulatory blood pressure measurement trials (question #3d)

Evidence Table 53: Effect of ambulatory blood pressure measurement interventions on clinic blood pressure (question #3d)

Evidence Table 54: Effect of ambulatory blood pressure measurement interventions on 24 Hour, daytime and nighttime ambulatory blood pressure (question #3d)

Copyright Notice

Bookshelf ID: NBK36702

Views

PubReader
Print View
Cite this Page
Appel LJ, Robinson KA, Guallar E. Utility of Blood Pressure Monitoring Outside of the Clinic Setting. Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Nov. (Evidence Reports/Technology Assessments, No. 63.) Evidence Tables.

Other titles in these collections

Recent Activity

Clear Turn Off Turn On

Evidence Tables - Utility of Blood Pressure Monitoring Outside of the Clinic Set...
Evidence Tables - Utility of Blood Pressure Monitoring Outside of the Clinic Setting
Gabpb2 GA repeat binding protein, beta 2 [Mus musculus]
Gabpb2 GA repeat binding protein, beta 2 [Mus musculus]
Gene ID:213054
Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on